Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung()

Respiratory diseases are among the leading causes of morbidity and mortality worldwide, coupled with the ongoing coronavirus disease 2019 (COVID-19) pandemic. mRNA lipid nanoparticle (LNP) vaccines have been developed, but their intramuscular delivery limits pulmonary bioavailability. Inhalation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Popowski, Kristen D., López de Juan Abad, Blanca, George, Arianna, Silkstone, Dylan, Belcher, Elizabeth, Chung, Jaewook, Ghodsi, Asma, Lutz, Halle, Davenport, Jada, Flanagan, Mallory, Piedrahita, Jorge, Dinh, Phuong-Uyen C., Cheng, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier, inc 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213043/
https://www.ncbi.nlm.nih.gov/pubmed/36523538
http://dx.doi.org/10.1016/j.vesic.2022.100002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213043/
https://www.ncbi.nlm.nih.gov/pubmed/36523538
http://dx.doi.org/10.1016/j.vesic.2022.100002

Ejemplares similares